Causes of death among persons who survive an acute ischemic stroke

Current Neurology and Neuroscience Reports

Volumn 14, Issue 8, 2014, Pages

  Zhang, Shuai ^a   He, Wen Bin ^a,b   Chen, Nai Hong ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b SHANXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Cardiovascular complications; Pneumonia; Stroke; Subsequent death; Vascular embolism

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; LEVOFLOXACIN; LOW MOLECULAR WEIGHT HEPARIN; MOXIFLOXACIN; PROPRANOLOL; WARFARIN;

BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; EMBOLISM; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE INJURY; HUMAN; INFECTION; LUNG EMBOLISM; MORTALITY; NONHUMAN; PNEUMONIA; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURVIVOR; CARDIOVASCULAR DISEASES; COMPLICATION;

BRAIN ISCHEMIA; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; EMBOLISM; HUMANS; PNEUMONIA; STROKE;

EID: 84902747040     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-014-0467-3     Document Type: Review

References (114)

1. Johnston KC, Li JY, Lyden PD, Hanson SK, Feasby TE, Adams RJ, et al. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. Stroke. 1998;29:447-53. (Pubitemid 28086690)
2. Hong KS, Kang DW, Koo JS, Yu KH, Han MK, Cho YZ, et al. Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. Eur J Neurol. 2008;15:1324-31.
3. Balami JS, Chen RL, Grunwald IQ, Buchan AM. Neurological complications of acute ischaemic stroke. Lancet Neurol. 2011;10:357-71.
4. Kumar S, Selim MH, Caplan LR. Medical complications after stroke. Lancet Neurol. 2010;9:105-18.
5. Vernino S, Brown Jr RD, Sejvar JJ, Sicks JD, Petty GW, O'Fallon WM. Cause-specific mortality after first cerebral infarction: a population-based study. Stroke. 2003;34:1828-32. (Pubitemid 36944762)
6. Viitanen M, Winblad B, Asplund K. Autopsy-verified causes of death after stroke. Acta Med Scand. 1987;222:401-8.
7. Dennis MS, Burn JP, Sandercock PA, Bamford JM, Wade DT, Warlow CP. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke. 1993;24:796-800. (Pubitemid 23163551)
8. Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, et al. Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke. 2000;31:2080-6.
9. Brønnum-Hansen H, Davidsen M, Thorvaldsen P. Long-term survival and causes of death after stroke. Stroke. 2001;32:2131-6. (Pubitemid 32868112)
10. Hardie K, Hankey GJ, Jamrozik K, Broadhurst RJ, Anderson C. Ten-year survival after first-ever stroke in the Perth Community Stroke Study. Stroke. 2003;34:1842-6. (Pubitemid 36944765)
11. Slot KB, Berge E, Dorman P, Lewis S, Dennis M, Sandercock P. Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies. BMJ. 2008;336:376-9. (Pubitemid 351300373)
12. Slot KB, Berge E, Sandercock P, Lewis SC, Dorman P, Dennis M. Causes of death by level of dependency at 6 months after ischemic stroke in 3 large cohorts. Stroke. 2009;40:1585-9.
13. Efstathiou SP, Tsioulos DI, Tsiakou AG, Gratsias YE, Pefanis AV, Mountokalakis TD. Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke. 2005;36:1915-9. (Pubitemid 41266526)
14. Alberti A, Agnelli G, Caso V, Venti M, Acciarresi M, D'Amore C, et al. Non-neurological complications of acute stroke: frequency and influence on clinical outcome. Intern Emerg Med. 2011;6:S119-23.
15. Schaller BJ, Graf R, Jacobs AH. Pathophysiological changes of the gastrointestinal tract in ischemic stroke. Am J Gastroenterol. 2006;101:1655-65. (Pubitemid 43980643)
16. • Pongmoragot J, Rabinstein AA, Nilanont Y, Swartz RH, Zhou L, Saposnik G. Pulmonary embolism in ischemic stroke: clinical presentation, risk factors, and outcome. J Am Heart Assoc. 2013;2:e000372. Because of limited information currently, this large cohort study evaluated the clinical characteristics, risk factors, and outcomes of PE in patients with acute ischemic stroke. It provides more evidence to show that this serious complication is associated with a higher risk of death and worse disability in stroke patients.
17. Kallmünzer B, Breuer L, Kahl N, Bobinger T, Raaz-Schrauder D, Huttner HB, et al. Serious cardiac arrhythmias after stroke incidence, time course, and predictors: a systematic, prospective analysis. Stroke. 2012;43:2892-7.
18. Frangiskakis JM, Hravnak M, Crago EA, Tanabe M, Kip KE, Gorcsan J, et al. Ventricular arrhythmia risk after subarachnoid hemorrhage. Neurocrit Care. 2009;10:287-94.
19. Ay H, Koroshetz WJ, Benner T, Vangel MG, Melinosky C, Arsava EM, et al. Neuroanatomic correlates of stroke-related myocardial injury. Neurology. 2006;66:1325-9. (Pubitemid 43739638)
20. Elkind MSV. Outcomes after stroke: risk of recurrent ischemic stroke and other events. Am J Med. 2009;122:S7-13.
21. Liao J, O'Donnell MJ, Silver FL, Thiruchelvam D, Saposnik G, Fang J, et al. In-hospital myocardial infarction following acute ischaemic stroke: an observational study. Eur J Neurol. 2009;16:1035-40.
22. Dhamoon MS, Tai W, Boden-Albala B, Rundek T, Paik MC, Sacco RL, et al. Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke. 2007;38:1752-8. (Pubitemid 46847244)
23. Touze E, Varenne O, Chatellier G, Peyrard S, Rothwell PM, Mas JL. Risk ofmyocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke. 2005;36:2748-55.
24. House A, Knapp P, Bamford J, Vail A. Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month. Stroke. 2001;32:696-701.
25. Goldhaber SZ. Pulmonary embolism. Lancet. 2004;363:1295-305. (Pubitemid 38496494)
26. CLOTS Trials Collaboration. Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet. 2009;373:1958-65.
27. Kohro S, Yamakage M, Sato K, Sato JI, Namiki A. Intermittent pneumatic foot compression can activate blood fibrinolysis without changes in blood coagulability and platelet activation. Acta Anaesthesiol Scand. 2005;49:660-4. (Pubitemid 40593511)
28. Thijs V, Lemmens R, Schoofs C, Görner A, Van Damme P, Schrooten M, et al. Microbleeds and the risk of recurrent stroke. Stroke. 2010;41:2005-9.
29. Boulanger JM, Coutts SB, Eliasziw M, Gagnon AJ, Simon JE, Subramaniam S, et al. Cerebral microhemorrhages predict new disabling or fatal strokes in patients with acute ischemic stroke or transient ischemic attack. Stroke. 2006;37:911-4. (Pubitemid 43731932)
30. Imaizumi T, Inamura S, Kohama I, Yoshifuji K, Nomura T, Komatsu K. Nascent lobar microbleeds and stroke recurrences. J Stroke Cerebrovasc Dis. 2014;23:610-7.
31. Imaizumi T, Inamura S, Kohama I, Yoshifuji K, Nomura T, Komatsu K. Nascent deep microbleeds and stroke recurrences. J Stroke Cerebrovasc Dis. 2014;23:520-8.
32. Sen S, Hinderliter A, Sen PK, Simmons J, Beck J, Offenbacher S, et al. Aortic arch atheroma progression and recurrent vascular events in patients with stroke or transient ischemic attack. Circulation. 2007;116:928-35. (Pubitemid 47300917)
33. Lechat PH, Mas JL, Lascault G, Loron PH, Theard M, Klimczac M, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318:1148-52.
34. Webster MWI, Smith HJ, Sharpe WN, Chancellor AM, Swift DL, Bass NM, et al. Patent foramen ovale in young stroke patients. Lancet. 1988;2:11-2.
35. Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, Hermanek P, Leffmann C, Janzen RW, et al. Predictors of inhospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med. 2004;164:1761-8. (Pubitemid 39215645)
36. Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW. The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology. 2003;60:620-5. (Pubitemid 36246079)
37. Finlayson O, Kapral M, Hall R, Asllani E, Selchen D, Saposnik G. Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke. Neurology. 2011;77:1338-45.
38. •• Chamorro Á, Meisel A, Planas AM, Urra X, van de Beek D, Veltkamp R. The immunology of acute stroke. Nat Rev Neurol. 2012;8:401-10. This important review suggests an immunologic mechanism in stroke. Chamorro et al. thoroughly illustrate the multifaceted role of the immune system in the pathophysiology of acute stroke, which is significant for future studies.
39. van de Beek D, Wijdicks EF, Vermeij FH, de Haan RJ, Prins JM, Spanjaard L, et al. Preventive antibiotics for infections in acute stroke: a systematic review and meta-analysis. Arch Neurol. 2009;66:1076-81.
40. Aslanyan S, Weir CJ, Diener HC, Kaste M, Lees KR. Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol. 2004;11:49-53. (Pubitemid 38174922)
41. Hilker R, Poetter C, Findeisen N, Sobesky J, Jacobs A, Neveling M, et al. Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke. 2003;34:975-81. (Pubitemid 36402972)
42. Liesz A, Hagmann S, Zschoche C, Adamek J, Zhou W, Sun L, et al. The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke. 2009;40:2849-58.
43. Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and ismediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med. 2003;198:725-36. (Pubitemid 37087772)
44. • Brait VH, Arumugam TV, Drummond GR, Sobey CG. Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia. J Cereb Blood Flow Metab. 2012;32:598-611. This novel and important review provides much information about the pathogenic role of Tcellss in ischemic stroke based on the current reports. More importantly, it indicates the actions of different T-cell subtypes in stroke-induced immunodeficiency syndrome and ischemic injury. All these are helpful in understanding the mechanism of stroke and planning clinical treatment.
45. Saino O, Taguchi A, Nakagomi T, Nakano-Doi A, Kashiwamura S, Doe N, et al. Immunodeficiency reduces neural stem/progenitor cell apoptosis and enhances neurogenesis in the cerebral cortex after stroke. J Neurosci Res. 2010;88:2385-97.
46. Trakhtenberg EF, Goldberg JL. Neuroimmune communication. Science. 2011;334:47-8.
47. Hurn PD, Subramanian S, Parker SM, Afentoulis ME, Kaler LJ, Vandenbark AA, et al. T- and B-cell deficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Blood Flow Metab. 2007;27:1798-805. (Pubitemid 47624547)
48. Brait VH, Jackman KA, Walduck AK, Selemidis S, Diep H, Mast AE, et al. Mechanisms contributing to cerebral infarct size after stroke: gender, reperfusion, T lymphocytes, and Nox2-derived superoxide. J Cereb Blood Flow Metab. 2010;30:1306-17.
49. Liesz A, Zhou W, Mracsko E, Karcher S, Bauer H, Schwarting S, et al. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain. 2011;134:704-20.
50. Ibañez A, Gleichgerrcht E, Manes F. Clinical effects of insular damage in humans. Brain Struct Funct. 2010;214:397-410.
51. •• Walter U, Kolbaske S, Patejdl R, Steinhagen V, Abu-Mugheisib M, Grossmann A, et al. Insular stroke is associated with acute sympathetic hyperactivation and immunodepression. Eur J Neurol. 2013;20:153-9. Walter et al. conducted a study in a subcohort of the Predictors of Early Chest Infection in Acute Ischemic Stroke trial and found that insular lesions were associated with immunodeficiency. Large infarctions (more than 33% of MCA area) and insular lesions caused infectious complications, especially chest infections. This evidence supports the idea that damage to a specific region in the brain is associated with stroke-induced infectious complications.
52. Wong CH, Jenne CN, Lee WY, Léger C, Kubes P. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science. 2011;334:101-5.
53. Minnerup J, Wersching H, Brokinkel B, Dziewas R, Heuschmann PU, Nabavi DG, et al. The impact of lesion location and lesion size on poststroke infection frequency. J Neurol Neurosurg Psychiatry. 2010;81:198-202.
54. Martino R, Foley N, Bhogal S, Diamant N, Speechley M, Teasell R. Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke. 2005;36:2756-63.
55. Sellars C, Bowie L, Bagg J, Sweeney MP, Miller H, Tilston J, et al. Risk factors for chest infection in acute stroke: a prospective cohort study. Stroke. 2007;38:2284-91. (Pubitemid 47457570)
56. 2) to predict pneumonia in acute ischemic stroke. Stroke. 2012;43:2617-23.
57. Meisel C, Prass K, Braun J, Victorov I, Wolf T, Megow D, et al. Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Stroke. 2004;35:2-6. (Pubitemid 38057579)
58. Chamorro A, Horcajada JP, Obach V, Vargas M, Revilla M, Torres F, et al. The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial. Stroke. 2005;36:1495-500. (Pubitemid 40967519)
59. Schäbitz WR. Regulatory T, cells in ischemic stroke helpful or hazardous? Stroke. 2013;44:e84.
60. Prass K, Braun JS, Dirnagl U, Meisel C, Meisel A. Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke. 2006;37:2607-12. (Pubitemid 44454686)
61. Micieli G, Cavallini A. The autonomic nervous system and ischemic stroke: a reciprocal interdependence. Clin Auton Res. 2008;18:308-17.
62. Hilz MJ, Moeller S, Akhundova A, Marthol H, Pauli E, De Fina P, et al. High NIHSS values predict impairment of cardiovascular autonomic control. Stroke. 2011;42:1528-33.
63. Nagai M, Hoshide S, Kario K. The insular cortex and cardiovascular system: a new insight into the brain-heart axis. J Am Soc Hypertens. 2010;4:174-82.
64. Varnavas GG, Grand W. The insular cortex: morphological and vascular anatomic characteristics. Neurosurgery. 1999;44:127-36.
65. Cheung RT, Hachinski V. The insula and cerebrogenic sudden death. Arch Neurol. 2000;57:1685-8.
66. Abboud H, Berroir S, Labreuche J, Orjuela K, Amarenco P. Insular involvement in brain infarction increases risk for cardiac arrhythmia and death. Ann Neurol. 2006;59:691-9.
67. Colivicchi F, Bassi A, Santini M, Caltagirone C. Prognostic implications of right-sided insular damage, cardiac autonomic derangement, and arrhythmias after ischemic stroke. Stroke. 2005;36:1710-5. (Pubitemid 41098767)
68. Laowattana S, Zeger SL, Lima JA, Goodman SN, Wittstein IS, Oppenheimer SM. Left insular stroke is associated with adverse cardiac outcome. Neurology. 2006;66:477-83. (Pubitemid 43739871)
69. Sander D, Winbeck K, Klingelhofer J, Etgen T, Conrad B. Prognostic relevance of pathological sympathetic activation after acute thromboembolic stroke. Neurology. 2001;57:833-8. (Pubitemid 32845504)
70. Min WK, Park KK, Kim YS, Park HC, Kim JY, Park SP, et al. Atherothrombotic middle cerebral artery territory infarction topographic diversity with common occurrence of concomitant small cortical and subcortical infarcts. Stroke. 2000;31:2055-61.
71. Hilz MJ, Dutsch M, Perrine K, Nelson PK, Rauhut U, Devinsky O. Hemispheric influence on autonomic modulation and baroreflex sensitivity. Ann Neurol. 2001;49:575-84. (Pubitemid 32429784)
72. Christensen H, Boysen G, Christensen AF, Johannesen HH. Insular lesions, ECG abnormalities, and outcome in acute stroke. J Neurol Neurosurg Psychiatry. 2005;76:269-71. (Pubitemid 40143724)
73. Katsanos AH, Korantzopoulos P, Tsivgoulis G, Kyritsis AP, Kosmidou M, Giannopoulos S. Electrocardiographic abnormalities and cardiac arrhythmias in structural brain lesions. Int J Cardiol. 2013;167:328-34.
74. Meyer S, Strittmatter M, Fischer C, Georg T, Schmitz B. Lateralization in autonomic dysfunction in ischemic stroke involving the insular cortex. Neuroreport. 2004;15:357-61. (Pubitemid 38297365)
75. Sykora M, Diedler J, Rupp A, Turcani P, Steiner T. Impaired baroreceptor reflex sensitivity in acute stroke is associated with insular involvement, but not with carotid atherosclerosis. Stroke. 2009;40:737-42.
76. Robinson TG, Dawson SL, Eames PJ, Panerai RB, Potter JF. Cardiac baroreceptor sensitivity predicts long-term outcome after acute ischemic stroke. Stroke. 2003;34:705-12.
77. McLaren A, Kerr S, Allan L, Steen IN, Ballard C, Allen J, et al. Autonomic function is impaired in elderly stroke survivors. Stroke. 2005;36:1026-30. (Pubitemid 40629297)
78. Dütsch M, Burger M, Dörfler C, Schwab S, Hilz MJ. Cardiovascular autonomic function in poststroke patients. Neurology. 2007;69:2249-55. (Pubitemid 350294681)
79. Ishikawa H, Tajiri N, Vasconcellos J, Kaneko Y, Mimura O, Dezawa M, et al. Ischemic stroke brain sends indirect cell death signals to the heart. Stroke. 2013;44:3175-82.
80. Sykora M, Diedler J, Turcani P, Hacke W, Steiner T. Baroreflex: a new therapeutic target in human stroke? Stroke. 2009;40:e678-82.
81. Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, Hohnloser SH, et al. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy. Circulation. 2012;125:1605-16.
82. Takahashi T, Yücel M, Lorenzetti V, Tanino R, Whittle S, Suzuki M, et al. Volumetric MRI study of the insular cortex in individuals with current and pastmajor depression. J Affect Disord. 2010;121:231-8.
83. Feng W, Hendry RM, Adams RJ. Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients. Neurology. 2010;74:588-93.
84. Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2001;345:1444-51.
85. Harvey RL. Prevention of venous thromboembolism after stroke. Top Stroke Rehabil. 2003;10:61-9. (Pubitemid 37448979)
86. Chen CC, Lee TH, Chung CY, Chang WH, Hong JP, Huang LT, et al. Symptomatic pulmonary embolism among stroke patients in Taiwan: a retrospective cohort study. Top Stroke Rehabil. 2012;19:361-8.
87. Stein PD, Fowler SE, Goodman LR, Gottschalk A, Hales CA, Hull RD, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. 2006;354:2317-27. (Pubitemid 43801277)
88. Kamphuisen PW, Agnelli G. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke? Thromb Res. 2007;119:265-74. (Pubitemid 44920433)
89. Lederle FA, Zylla D, MacDonald R, Wilt TJ. Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2011;155:602-15.
90. Naccarato M, Chiodo Grandi F, Dennis M, Sandercock PA. Physical methods for preventing deep vein thrombosis in stroke. Cochrane Database Syst Rev. 2010;(8):CD001922.
91. Ryglewicz D, Baranska-Gieruszczak M, Czlonkowska A, Lechowicz W, Hier DB. Stroke recurrence among 30 days survivors of ischemic stroke in a prospective community-based study. Neurol Res. 1997;19:377-9. (Pubitemid 27335145)
92. Brown DL, Lisabeth LD, Roychoudhury C, Ye Y, Morgenstern LB. Recurrent stroke risk is higher than cardiac event risk after initial stroke/transient ischemic attack. Stroke. 2005;36:1285-7. (Pubitemid 40798753)
93. Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008;359:1238-51.
94. Dearani JA, Ugurlu BS, Danielson GK, Daly RC, McGregor CG, Mullany CJ, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism- related cerebrovascular ischemic events. Circulation. 1999;100:II171-5. (Pubitemid 29523530)
95. Khan AR, Bin Abdulhak AA, Sheikh MA, Khan S, Erwin PJ, Tleyjeh I, et al. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis. JACC Cardiovasc Interv. 2013;6:1316-23.
96. Rengifo-Moreno P, Palacios IF, Junpaparp P, Witzke CF, Morris DL, Romero-Corral A. Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials. Eur Heart J. 2013;34:3342-52.
97. Kent D, Kitsios G, Hill MD, Almekhlafi MA, Wilton SB, Ghali WA. Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis. Neurology. 2011;77:301-2.
98. Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366:991-9.
99. Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013;368:1092-100.
100. Awadh M, MacDougall N, Santosh C, Teasdale E, Baird T, Muir KW. Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation. Stroke. 2010;41:1990-5.
101. Di Tullio MR, Russo C, Jin Z, Sacco RL, Mohr JP, Homma S. Aortic arch plaques and risk of recurrent stroke and death. Circulation. 2009;119:2376-82.
102. Weimar C, Benemann J, Michalski D, Müller M, Luckner K, Katsarava Z, et al. Prediction of recurrent stroke and vascular death in patients with transient ischemic attack or nondisabling stroke: a prospective comparison of validated prognostic scores. Stroke. 2010;41:487-93.
103. Weimar C, Diener HC, Alberts MJ, Steg PG, Bhatt DL, Wilson PW, et al. The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registry. Stroke. 2009;40:350-4.
104. Coutts SB, Modi J, Patel SK, Demchuk AM, Goyal M, Hill MD. CT/CT angiography and MRI findings predict recurrent stroke after transient ischemic attack and minor stroke: results of the prospective CATCH study. Stroke. 2012;43:1013-7.
105. Eriksson SE, Olsson JE. Survival and recurrent strokes in patients with different subtypes of stroke: a fourteen-year follow-up study. Cerebrovasc Dis. 2001;12:171-80.
106. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:227-76.
107. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke. 2003;34:2741-8. (Pubitemid 37392777)
108. Ovbiagele B, Diener HC, Yusuf S, Martin RH, Cotton D, Vinisko R, et al. Level of systolic blood pressure within the normal range and risk of recurrent stroke. JAMA. 2011;306:2137-44.
109. Pezzini A, Del Zotto E, Magoni M, Costa A, Archetti S, Grassi M, et al. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke. 2003;34:28-33. (Pubitemid 36070795)
110. Kartunnen B, Hiltunen L, Rasi V, Vahtera E, Hillbom M. Factor V Leiden and prothrombin gene mutations may predispose to paradoxical embolism in subjects with patent foramen ovale. Blood Coagul Fibrinolysis. 2003;14:261-8.
111. Lichy C, Reuner KH, Buggle F, Litfin F, Rickmann H, Kunze A, et al. Prothrombin G20210A mutation, but not factor V Leiden, is a risk factor in patients with persistent foramen ovale and otherwise unexplained cerebral ischemia. Cerebrovasc Dis. 2003;16:83-7. (Pubitemid 36677001)
112. Alberts MJ. Antithrombotic therapy for secondary stroke prevention. Continuum (Minneap Minn). 2011;17:1255-66.
113. Weir CJ, Muir SW, Walters MR, Lees KR. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke. 2003;34:1951-6. (Pubitemid 36944787)
114. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60:1581-98.